Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease
Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease
评估代谢手术与最佳药物治疗对 2 型糖尿病和心血管疾病的额外疗效
批准号：
446722
负责人：
Farkouh Michael E
金额：
$0.0万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2021-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart disease is the leading cause of death among people with type 2 diabetes. The evidence suggests that lowering blood sugar alone is not enough to prevent heart disease. Some diabetes medications prevent heart disease, but how they do so is not known.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
